Evidence map›Paper›PMID 34678482›Full record

ArticleComputers in biology and medicine2021

Assessing population-sampling strategies for reducing the COVID-19 incidence.

Miguel Guzmán-Merino, Christian Durán, Maria-Cristina Marinescu, Concepción Delgado-Sanz, Diana Gomez-Barroso, Jesus Carretero, David E Singh

Open access · hybridAbstract read
In one paragraph

Article in Computers in biology and medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
1.2field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it, 14 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Miguel Guzmán-MerinoUniversidad Carlos III de Madrid, Leganes, Spain.
Christian DuránUniversidad Carlos III de Madrid, Leganes, Spain.
Maria-Cristina MarinescuBarcelona Supercomputing Center, Barcelona, Spain.
Concepción Delgado-SanzCIBER en Epidemiología y Salud Pública (CIBERESP), Madrid, Spain; National Centre for Epidemiology, Carlos III Institute of Health, Madrid, Spain.
Diana Gomez-BarrosoCIBER en Epidemiología y Salud Pública (CIBERESP), Madrid, Spain; National Centre for Epidemiology, Carlos III Institute of Health, Madrid, Spain.
Jesus CarreteroUniversidad Carlos III de Madrid, Leganes, Spain.
David E SinghUniversidad Carlos III de Madrid, Leganes, Spain. Electronic address: dexposit@inf.uc3m.es.
Universidad Carlos III de Madrid · ESInstituto de Salud Carlos III · ESBarcelona Supercomputing Center · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

As long as critical levels of vaccination have not been reached to ensure heard immunity, and new SARS-CoV-2 strains are developing, the only realistic way to reduce the infection speed in a population is to track the infected individuals before they pass on the virus. Testing the population via sampling has shown good results in slowing the epidemic spread. Sampling can be implemented at different times during the epidemic and may be done either per individual or for combined groups of people at a time. The work we present here makes two main contributions. We first extend and refine our scalable agent-based COVID-19 simulator to incorporate an improved socio-demographic model which considers professions, as well as a more realistic population mixing model based on contact matrices per country. These extensions are necessary to develop and test various sampling strategies in a scenario including the 62 largest cities in Spain; this is our second contribution. As part of the evaluation, we also analyze the impact of different parameters, such as testing frequency, quarantine time, percentage of quarantine breakers, or group testing, on sampling efficacy. Our results show that the most effective strategies are pooling, rapid antigen test campaigns, and requiring negative testing for access to public areas. The effectiveness of all these strategies can be greatly increased by reducing the number of contacts for infected individual.

Indexed as

COVID-19HumansIncidenceSARS-CoV-2SpainAgent-based simulationContact matricesSampling strategiesSARS-CoV-2(COVID-19)Social model

Identifiers

PMID34678482
PMCPMC8507586
OpenAlexW3205903567

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.